Caio Suartz
@CSuartz
Followers
426
Following
1K
Media
51
Statuses
199
Assist Professor: @thenosm / Uro Oncologist: @TBRHSF Former Clin Fellow @LavalUniversity Former Res.fellow: UniversitéParis
São Paulo
Joined August 2020
Starting our prostate cancer lecture marathon this Saturday, marking the beginning of Movember with the Brazilian Society of Urology. Register at the link! 🔗
1
0
0
0
0
0
This Thursday, we will discuss the most important studies in uro-oncology presented at the ESMO 2025 Congress. Some of them may even change our clinical practice. Join this free event and receive a certificate through the link: https://t.co/jHELRclD8s
1
0
2
🚨Oncology: Here & Now🚨 An honor to discuss such important topics with the great @dandanmena from @UroTeragLATAM ✨ @wroclawski_uro @WbusatoJr @CSuartz @albertotm82 @clovis_fraga @psalustiano @DrMourato @MSdoNascimento @Lfsala
@anacardosomd @drdanielvargas @FabioSchutz
Dear Colleagues at #ESMO25 Oncology: Here & Now is BACK ‼️ S2E1 GU Oncology 🚨 Listen Here: https://t.co/b2PlnRhrod Join @bavilima 🇧🇷& @dandanmena 🇲🇽 on this Great Webcast as they discuss #ProstateCancer : ✅Rationale between BULLSEYE🎯 Trial ✅Difference Between Lutetium &
0
7
11
#BladderCancer #ESMO25
@OncoAlert coverage and @PGrivasMDPhD with the highlights from ✨Keynote 905 ✨DV + Toripalimab ✨IMvigor011 @wroclawski_uro @philippespiess
@WbusatoJr @CSuartz @albertotm82 @clovis_fraga @psalustiano @DrMourato @MSdoNascimento @Lfsala
@anacardosomd
Dear Colleagues at #ESMO25 A Great pleasure to Introduce our Faculty Dr. Petros Grivas 🇺🇸 from Fred Hutch who talks to us about all of the Exciting #BladderCancer Science being Presented in Berlin ✅ Keynote 905 ✅ Disitamab vedotin (DV) plus toripalimab ✅ IMvigor011 And
0
7
9
Ali (PGY-1) assisted in his first robotic radical prostatectomy at the bedside , an excellent start with a full nerve-sparing. Good Job @thenosm @NOSMUUrology @ShahrourWalid
1
1
6
The CRASH-2 trial proved tranexamic acid helps in trauma. But does it help in radical cystectomy? The answer is no. Our meta-analysis (1,736 pts) published this month in the @CuaJournal explains why. Grateful to my amazing co-authors
2
2
5
Hoje vamos discutir um tema essencial para quem deseja seguir carreira em urologia: Residência Médica em Urologia no Brasil e nos Estados Unidos. Também vamos explorar as opções de fellowship e a sua importância na formação do urologista.
0
0
0
Today we will discuss an essential topic for those pursuing a career in urology: Urology Residency in Brazil and the United States. We will also explore the different fellowship opportunities and their importance in the training of urologists, addressing academic,clinical career.
3
0
7
Always great OncoAlert RoundUp🚨 #ProstateCancer : PRIME Trial‼️Biparametric MRI noninferior to mpMRI @CSuartz @wroclawski_uro @psalustiano REGISTER HERE 👉
The OncoAlert WEEKLY RoundUp 🚨 Covering the TOP of the week Sept 12-18, 2025 REGISTER at https://t.co/yzt83gqQkF OR https://t.co/dq8GEzl9ps Discussing: 🔹 PRIME Diagnostic Trial (JAMA): Biparametric MRI is noninferior to multiparametric MRI for #ProstateCancer 🔹
0
6
10
End of #ERUS25 Time to head home with new surgical techniques, research ideas, and new friends. An excellent congress. Congratulations @AlbertoBreda1 and all the team for this impressive meeting.
0
0
2
🚨Online now: TAR-200 plus cetrelimab versus cetrelimab monotherapy as neoadjuvant therapy in muscle-invasive #bladdercancer who are ineligible for or decline neoadjuvant cisplatin-based chemotherapy (SunRISe-4): interim analysis of a phase 2 trial https://t.co/MOH1m04kge
2
9
31
Neoadjuvant Immunotherapy in Bladder Cancer: Ushering in a New Era of Treatment—A Systematic Review of Current Evidence https://t.co/cAFEEV2aZS
2
1
4